Clinical Trial Phases (Drug Studies) Flashcards
Which clinical trial phase does this describe:
- Delineate additional information about the drug’s risk, benefits and optimal use; continue assessing overall therapeutic value
Phase 4
Which clinical trial phase does this describe:
- Combined population from several hundred to several thousand subjects
Phase 3
Which clinical trial phase does this describe:
- Assess overall therapeutic value
Phase 3
Which clinical trial phase does this describe:
- Obtain short-term safety data
Phase 2
Which clinical trial phase does this describe:
- Address FDA requirements for additional information not in NDA
Phase 4
Which clinical trial phase does this describe:
- Usually conducted at phase-specific units, tightly controlled, in-patient setting
Phase 1
Which clinical trial phase does this describe:
- Establish long-term efficacy and safety, as appropriate
Phase 3
Which clinical trial phase does this describe:
- Relatively small number of subjects per study
Phase 2
Which clinical trial phase does this describe:
- Additional evidence of efficacy and safety
Phase 3
Which clinical trial phase does this describe:
- Multi-center, well-controlled studies
Phase 2
Which clinical trial phase does this describe:
- Small numbers of subjects per study and overall: generally in the range of 20 to 80.
Phase 1
Which clinical trial phase does this describe:
- Confirmation of short-term efficacy and safety
Phase 3
Which clinical trial phase does this describe:
- May be similar to Phase 2 or Phase 3 studies in design
Phase 4
Which clinical trial phase does this describe:
- Design and number of subjects depends on study objective
Phase 4
Which clinical trial phase does this describe:
- Usually single-center studies
Phase 1
Which clinical trial phase does this describe:
- Normal volunteers or subjects with condition under study
Phase 1
Which clinical trial phase does this describe:
- Initial demonstration of efficacy in subjects with the condition under investigation
Phase 2
Which clinical trial phase does this describe:
- Establish overall benefit-risk relationship
Phase 3
Which clinical trial phase does this describe:
- Surveillance for less common adverse events (spontaneous reports, registries)
Phase 4
Which clinical trial phase does this describe:
- Supports final labeling content
Phase 3
Which clinical trial phase does this describe:
- Expanded controlled and uncontrolled studies
Phase 3
Which clinical trial phase does this describe:
- Combined population “usually involving no more than several hundred subjects”
Phase 2